Addressing low treatment rates of chronic hepatitis C in injecting drug users: Why do injecting drug users not engage in treatment, what are the health and social benefits for those who do engage in treatment, and does nurse led initiation of antiviral therapy increase the proportion accepting and completing treatment?

Barts and the London NHS Trust (UK)0 个研究点目标入组 402 人开始时间: 2014年6月19日最近更新: 2017年4月3日

适应症

试验速览

暂无简介。

•1. Hepatitis C virus (HCV) positive (as shown by a positive HCV RNA level)
•2. Attending Specialist Addiction Services in the boroughs of Hackney, Newham or Tower Hamlets in London

•1. A negative test for HCV infection
•2. People who are not registered with specialist addiction services
•3. Those who have evidence of any of the following:
•4. Cirrhosis of the liver - blood test, imaging or liver biopsy evidence
•5. Anaemia (low red cells) Haemoglobin <12
•6. Thrombocytopenia (low platelet count) <150
•7. Lymphopenia (low white cells) < 3
•8. Active infection of any kind
•9. Serious psychiatric disorders in the last two years
•4. Uncontrolled asthma
•5. Chronic obstructive pulmonary disease
•6. Ischaemic heart disease, or severe cardiac disease including ventricular arrhythmias, angina and heart failure, renal failure, autoimmune disease

发起方

Barts and the London NHS Trust (UK)